Named as a key player in 66 of our reports, across 33 regions and countries.
2023–2033 CAGR · estimates
| Market | Category | World 2023 | CAGR |
|---|---|---|---|
| Breast Cancer Diagnostic | Healthcare Services | $4.1 Bn | 7.8% |
| Brain Cancer Diagnostic | Healthcare Services | $1.5 Bn | 13.6% |
Named as key players in the same markets as Becton, Dickinson and Company (number of shared markets).
F. Hoffmann-La Roche Ltd2 shared markets
Illumina, Inc.2 shared markets
Siemens Healthineers2 shared markets
Thermo Fisher Scientific Inc.2 shared markets
Danaher Corporation1 shared market
Search all reports for Becton, Dickinson and Company All companies